Table 2

Draft of first step of search strategy to be used for at least two electronic databases.

#1((’tofacitinib' OR ’baricitinib' OR ’ruxolitinib' OR ’oclacitinib' OR ’upadacitinib' OR ’delgocitinib' OR ’itacitinib' OR ’momelotinib' OR peficitinib OR ’decernotinib' OR ’fedratinib' OR ’pacritinib' OR ’filgotinib' OR ’gandotinib' OR ’solcitinib' OR ’lestaurtinib' OR ’janus kinase inhibitor')
#2((’psoriasis'/exp OR psoriasis) OR ’atopic dermatitis' OR ’alopecia' OR ’contact dermatitis' OR ’vitiligo' OR ’graft versus host reaction' OR ’lichen planus' OR ’pyoderma gangrenosum' OR ’pruritus' OR (eosinofilic AND annulare AND erythema) OR ’male type alopecia' OR ’proteasome associated autoinflammatory syndrome' OR ’sting associated vasculopathy with onset in infancy' OR ’chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome' OR ’hand dermatitis' OR ’discoid lupus erythematosus' OR ’mucocutaneous candidiasis' OR (urticaria AND chronic) OR ’suppurative hidradenitis' OR ’melanoma' OR ’non melanoma skin cancer' OR ’acne' OR ’lichen sclerosus et atrophicus' OR ’pityriasis rubra pilaris' OR ’pemphigus' OR ’skin disease' OR ’rosaceae' OR ’scleroderma' OR ’cinca syndrome' OR ’hyperhidrosis' OR ’erythropoietic protoporphyria' OR ’anca associated vasculitis' OR ’seborrheic dermatitis' OR ’herpes simplex' OR ’sjoegren syndrome'))
#3#1 AND #2